Accessibility Menu
 
Smith & Nephew Plc logo

Smith & Nephew Plc

(NYSE) SNN

Current Price$34.18
Market Cap$14.66B
Since IPO (1999)+567%
5 Year-3%
1 Year+36%
1 Month+6%

Smith & Nephew Plc Financials at a Glance

Market Cap

$14.66B

Revenue (TTM)

$11.99B

Net Income (TTM)

$1.04B

EPS (TTM)

$1.44

P/E Ratio

23.78

Dividend

$0.78

Beta (Volatility)

0.70 (Low)

Price

$34.18

Volume

957,954

Open

$34.11

Previous Close

$34.21

Daily Range

$34.02 - $34.42

52-Week Range

$25.45 - $38.79

SNN: Motley Fool Moneyball Superscore

73

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Smith & Nephew Plc

Industry

Healthcare Equipment and Supplies

Employees

18,362

CEO

Deepak S Nath, PhD

Headquarters

Watford, WD18 8YE, GB

SNN Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

16%

Net Income Margin

10%

Return on Equity

12%

Return on Capital

12%

Return on Assets

6%

Earnings Yield

4.21%

Dividend Yield

0.02%

Payout Ratio

52.80%

Stock Overview

Market Cap

$14.66B

Shares Outstanding

426.54M

Volume

957.95K

Short Interest

0.00%

Avg. Volume

859.62K

Financials (TTM)

Gross Profit

$4.20B

Operating Income

$1.01B

EBITDA

$1.58B

Operating Cash Flow

$1.29B

Capital Expenditure

$434.01M

Free Cash Flow

$853.99M

Cash & ST Invst.

$557.00M

Total Debt

$3.33B

Smith & Nephew Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$3.19B

+13.3%

Gross Profit

$2.09B

+4.9%

Gross Margin

65.56%

N/A

Market Cap

$14.66B

N/A

Market Cap/Employee

$844.76K

N/A

Employees

17,349

N/A

Net Income

$330.82M

+263.5%

EBITDA

$856.21M

+57.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.77B

+0.4%

Accounts Receivable

$1.43B

+34.9%

Inventory

$2.12B

-11.6%

Long Term Debt

$3.18B

+37.0%

Short Term Debt

$150.00M

-80.4%

Return on Assets

6.10%

N/A

Return on Invested Capital

11.55%

N/A

Free Cash Flow

$594.67M

+153.1%

Operating Cash Flow

$888.43M

+79.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MEDPMedpace Holdings, Inc.
$528.44+1.51%
COOThe Cooper Companies, Inc.
$69.46-0.86%
NBIXNeurocrine Biosciences, Inc.
$131.59-1.25%
FMSFresenius Medical Care AG & Co. KGaA
$23.18-0.98%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.29-0.04%
NOKNokia
$10.60+0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$58.08-0.01%
AALAmerican Airlines Group
$12.24-0.04%

Questions About SNN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.